This webinar includes two presentations and a question and answer session. Dr James McKay, Deputy Head of the Genomic Epidemiology Branch at the International Agency for Research on Cancer (IARC), chaired the event.
In the first presentation, Dr Nilanjan Chatterjee, a Bloomberg Distinguished Professor of Biostatistics and Genetic Epidemiology at Johns Hopkins University, USA, provides a brief overview of emerging opportunities and discusses some limitations of the use of polygenic scores for developing risk-stratified approaches to cancer prevention.
In the second presentation, Dr Linda Kachuri, a Postdoctoral Scholar at the University of California San Francisco and an incoming Assistant Professor in the Department of Epidemiology and Population Health at Stanford University, USA, presents findings from the largest genome-wide association study of prostate-specific antigen (PSA) levels.